2023 Quality Assurance Reporting Requirements (QARR)

October 11, 2023

RE: Clarification #3 for Measurement Year (MY) 2023 Updates

Dear Colleague,

This letter contains information about edits incorporated into the 2023 Quality Assurance Reporting Requirements (QARR) Technical Specifications, Table 1 - QARR List of Required Measures, Patient Level Detail (PLD) for Measurement Year (MY) 2023 reporting, and the QARR Language Value set. The information contained in this clarification has been incorporated into a revised version of the QARR Technical Specifications for MY2023. The updated files are posted on our Managed Care Information for Health Plans page. The revised specifications should be used in the plans' processing for MY2023 QARR.

This clarification includes the following changes made to the MY2023 QARR reporting requirements.

Change Version Version Date Section(s) Changed Change Summary
3 10/11/2023 QARR Technical Specifications
  • Page 6, in the Non-NYS-Specific Measure Retired or Removed section; Appropriate Testing for Pharyngitis (CWP) has been removed for QHP Product Line ONLY, retired by Quality Rating System (QRS).
  • NYS Summary file Record Format for all Product lines table has been updated to include a Field length.
  • NYS Summary file Record Format for all Product lines table, the LOCATION field has been updated to account for the removal of the COL measure.
    Table 1 – QARR List of Required Measures
  • Appropriate Testing for Pharyngitis (CWP) is not required to be reported for Exchange product lines. Table 1 - QARR List of Required Measures inadvertently had this notated as required reporting (✓). This has been corrected to an NR.
    QARR Language Value set
  • The QARR Language Value has been updated to correct the Language Code in second occurrence of ENGLISH (001), row 57 of the worksheet
  • The QARR Language Value has been updated to correct the spelling of NEPALI, row 127 of the worksheet.
    Patient-Level Detail File (PLD) Commercial PLD:

General Info
  • Native Hawaiian/Pacific Islander Subgroups: Updated
    • 0=Not Native Hawaiian/Pacific Islander
Measure COL-E (electronic version):
  • Combo 2 – is Not required to be reported and has been removed.
  • Column Start and Column End numbering has been corrected throughout the PLD.
Measure COL
  • Denominator and Numerator specifications have been updated for 46-50 and 51-75 age-bands for this measure.
Measure COL-E (electronic version):
  • Denominator and Numerator specifications have been updated for 46-50 and 51-75 age-bands for this measure.
      Medicaid PLD:

General Info
  • Native Hawaiian/Pacific Islander Subgroups: Updated
    • 0=Not Native Hawaiian/Pacific Islander
Measure COL:
  • Denominator and Numerator specifications have been updated for 46-50 and 51-75 age-bands for this measure.
Measure COL-E (electronic version):
  • Denominator and Numerator specifications have been updated for 46-50 and 51-75 age-bands for this measure.
      Exchange PLD:

General Info
  • Native Hawaiian/Pacific Islander Subgroups: Updated
    • 0=Not Native Hawaiian/Pacific Islander
Measure COL-E (electronic version):
  • Denominator and Numerator specifications have been updated for 46-50 and 51-75 age-bands for this measure.
To align with CMS' Final Call letter for QRS, the following measures have been REMOVED as required reporting on the PLD:
  • Appropriate Testing for Pharyngitis (CWP)
  • Column Start and Column End numbering was corrected throughout the PLD.

If there are any questions about the above edits, or if you find issues or have concerns with the 2023 Technical Specifications manual or the 2023 Value Set, please email nysqarr@health.ny.gov.

Sincerely,

Paloma Luisi, MPH
Director, Bureau of Quality Measurement & Evaluation
Center for Applied Research and Evaluation
Office of Quality and Patient Safety

CC:  R. Josberger
        B. Bandle
        C. Fan